Victor MacDiarmid

Victor MacDiarmid

Associate

Victor MacDiarmid is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where he focuses on high-growth companies in the life sciences sector. Victor supports clients on general corporate matters, corporate governance, mergers & acquisitions, and capital-raising transactions, including venture financings.

Prior to joining the firm, Victor was an associate in Canada at the Toronto office of Stikeman Elliott LLP.

Experience

Prior to joining the firm, Victor was an associate in Canada at the Toronto office of Stikeman Elliott LLP.

Education

J.D., University of Toronto Faculty of Law, 2016
M.A., History of International Relations, University of Toronto, 2012
B.A. (Hons), International Relations, University of Toronto, 2011

Admissions

State Bar of California
Law Society of Ontario

Credentials

Education

J.D., University of Toronto Faculty of Law, 2016
M.A., History of International Relations, University of Toronto, 2012
B.A. (Hons), International Relations, University of Toronto, 2011

Admissions

State Bar of California
Law Society of Ontario

Corporate

Recent Insights

Client Highlights

On June 16, 2026, 4E Therapeutics, an Austin-based neuroscience company developing next-generation treatments for chronic pain, announced that it has been acquired by Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati advised 4E Therapeutics on the transaction.

Learn More

Client Highlights

On June 1, 2026, Resmed, a medical device company that develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders, announced it has closed on its acquisition of Noctrix Health, a medical device company that developed and manufactures a novel therapy to treat drug-refractory Restless Legs Syndrome (RLS) for $340 million. Wilson Sonsini Goodrich & Rosati advised Noctrix on the transaction.

Learn More